Skip to main content

View full-text article in PMC

. 2020 Oct 26;8:e10225. doi: 10.7717/peerj.10225

Table 1. The association between ZFPM2-AS1 expression and clinical measures in LUAD patients.

Characteristics	N	Relative ZFPM2-AS1 expression
		Low	High	P value
Age(years)
>65	11	5	6	0.733
≤65	39	20	19	0.733
Gender
Male	24	14	10	0.258
Female	26	11	15	0.258
Differentiation
Well,moderate	38	19	19	0.999
Poor	12	6	6	0.999
Tumor size (maximum diameter)
>3 cm	33	12	21	0.007^**
≤3 cm	17	13	4	0.007^**
Histological tumor type
Squamous cell carcinoma	20	8	12	0.248
Adenocarcinoma	30	17	13	0.248
Smoking history
Smokers	20	11	9	0.564
Never smokers	30	14	16	0.564
Lymph node metastasis
Positive	23	11	12	0.777
Negative	27	14	13	0.777
TNM stage
1stage	23	15	8	0.047^*
2.3.4stage	27	10	17	0.047^*

Notes.

Data were analyzed by Chi-square. Median value: 5.04.

^*

P < 0.05.

^**

P < 0.01.

Data were analyzed by Chisquare test. The high and low groups were divided by the median expression value of ZFPM2AS1 (5.04).